Navigation Links
Good Look Ink Announces Revolutionary Hair Replication Solution
Date:5/13/2010

Non surgical procedure restores the permanent look of a full head of hair in one day.

(Vocus) May 13, 2010 -- Good Look Inc (GLI) announced a revolutionary hair replication solution recently at their Edina, Mn, office. They utilize a new process known as Cosmetic Transdermal Hair Replication that works with every hair loss solution available. It restores the permanent look of a full head of hair in one day and develops confidence and comfort in men and women who suffer from baldness, thinning, or male pattern baldness.

"What amazes me about the result is how people's confidence in themselves goes up the day they are done," said GLI Owner Darrin Gerr.

The cosmetic transdermal hair replication process is different from any other options to date. The GLI technique is a non surgical hair replication technique that mimics both the color and density of a living hair follicle. Through the use of micro pigmentation, it employs the ingraining of indelible pigment, made on the scalp. When completed, it recreates the appearance of tens of thousands of individual hair follicles and is maintenance free.

Anyone with thinning hair, any degree of baldness due to genetics, alopecia, scars from hair transplants, burn scars, hair transplant recipients with unsatisfactory results, and those who wear hair systems and wigs are candidates for cosmetic transdermal hair replication. The high cost of maintenance that goes along with other solutions is eliminated and this process is affordable and competitively priced.

"I am 28 and have had 2 transplant surgeries and was considering my third. I came in to meet with a consultant. The consultant had the cosmetic transdermal hair replication done plus, he had scars from transplant surgery," said Allen a recent customer at GLI . "Well, I couldn't see them until he showed me, and I knew this was the pla
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Mammoth Selection Announces Revolutionary New Elite Air Purifier
2. Tattoo Removal Laser Clinic Announces New PhotoAcoustic Laser Technology
3. StopYourDrip.com Announces the Launch of a New Exercise Program to Improve Male Urinary Incontinence After Prostate Cancer Surgery
4. PHSI LLC Announces the Addition of New Technology from Audina Hearing Instruments
5. Quilmach LLC Announces the Introduction of QUILMACH.COM, the first Community Based Personal Advice Device on the Web
6. Parent Tested Parent Approved Media Announces their Winning Products for the Summer 2010 Campaign
7. Martin & Jones Announces Class Action Lawsuit Against Major Employer, Claims Thousands of Visiting Nurses Illegally Denied Overtime Pay
8. Mattress Warehouse Announces Its New Simmons Mattress Lineup
9. First Communications, Inc. Announces Audited Results for the Year Ended December 31, 2009
10. Java Planet, Tampa Bay's Newest Organic Coffee Company Announces That it Has Become Fair Trade Certified™
11. Urns.com Announces Urns As An Eco Friendly Burial Alternative
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Good Look Ink Announces Revolutionary Hair Replication Solution
(Date:5/22/2013)... Rochester, NY (PRWEB) May 22, 2013 ... can now have access to Adapt Courseware’s new ... curriculum in an adaptive framework that responds based ... Adapt Courseware , the provider of comprehensive adaptive ... experience, is continuing to develop introductory level general ...
(Date:5/22/2013)... Jersey (PRWEB) May 22, 2013 Ethos ... gift card system, fit for the busy lifestyle of the ... select a design appropriate for the occasion, whether it is ... an apology note, or any other occasion. , Clients should ... Jersey spa gift card designs on the Ethos Spa’s ...
(Date:5/22/2013)... TheBeautyPlace.com features Toppik and Bosley hair fibers, two ... of thinning or balding hair. Hair loss treatments can be ... hair loss during this waiting period, one can use these ... alternative to hair transplant surgery in general. , Bosley ... extremely effective way to eliminate the appearance of balding and ...
(Date:5/22/2013)... NJ (PRWEB) May 22, 2013 The health ... In some states, up to twenty-seven percent of all ... all bankruptcies of private citizens in the U.S. are related ... also affects prescription drugs, meaning that many patients cannot afford ... even get them filled at all. That's why MedicationDiscountCard.com ...
(Date:5/22/2013)... NJ (PRWEB) May 22, 2013 Officials ... today that its cicada services are now in full ... year that the cicada cycle emerges. , “The ... the year that they will emerge, so we’re now ... they are well protected during the invasion,” said R. ...
Breaking Medicine News(10 mins):Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 2Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 3Health News:Ethos Spa Skin And Laser Center Has Launched Their Customizable Gift Certificates 2Health News:TheBeautyPlace.com Divulges Two Innovative Hair Loss Concealers on the Market Today: Bosley Hair Thickening Fibers and Toppik Hair Building Fibers 2Health News:Lyrica Discount Cards Now Available From MedicationDiscountCard.com 2Health News:Alliance Commercial Pest Control, Inc. Now Offering Cicada Protection Services 2
... researcher has co-authored an international study that revealed a drug ... a rare lung disease in women. The life-threatening disease ... The clinical trial of the drug -- called sirolimus -- ... therapy for the lung disease, lymphangioleiomyomatosis, or LAM. LAM ...
... The wrist size of overweight or obese children and teens ... says a new study. Italian researchers measured the wrist ... They also used a painless nuclear imaging technique on about ... areas of the wrist more precisely. Blood tests were ...
... MONDAY, April 11 (HealthDay News) -- A drug commonly prescribed ... treating the mild stage of the disease, a new study ... effective in treating moderate to severe Alzheimer,s disease, "in mild ... works," said lead researcher Dr. Lon S. Schneider, a professor ...
... new discovery published online in The FASEB Journal ( ... likely to benefit from breast cancer drug therapies. If ... it would represent a significant advance for breast cancer ... some people. In addition, some drugs have side effects ...
... How your carotid artery moves can reveal your risk of ... study this vessel aspect in more detail thanks to a ... with suspected coronary artery disease, reveals a thesis from the ... arteries is associated with a risk of future heart disease, ...
... the journal Investigational New Drugs and conducted by researchers ... molecule inhibitors are showing promise in blocking STAT3, a ... osteosarcoma. These small molecule inhibitors one derived from ... as a new, non-toxic treatment for these deadly tumors. ...
Cached Medicine News:Health News:OHSU expert co-authors study finding treatment for rare lung disease 2Health News:Drug Memantine Ineffective for Mild Alzheimer's, Study Finds 2Health News:Drug Memantine Ineffective for Mild Alzheimer's, Study Finds 3Health News:Tiny antibody fragments raised in camels find drug targets in human breast cancer cells 2Health News:New potential atherosclerosis risk marker discovered 2Health News:New study finds compounds show promise in blocking STAT3 signaling as treatment for osteosarcoma 2
(Date:5/22/2013)... VANCOUVER, British Columbia , May 22, 2013  OncoGenex ... the development of novel therapeutics to target mechanisms of treatment ... investigational compounds, custirsen and OGX-427, will be presented as "Trials ... of the American Society of Clinical Oncology (ASCO) in ... 4. Despite the availability of drugs that ...
(Date:5/21/2013)... , May 21, 2013 Reaching a ... process, the National Association of Boards of Pharmacy ® ... the .PHARMACY domain suffix has passed the Internet Corporation ... intends to launch the .PHARMACY gTLD by the end ... to legitimate online pharmacies and related entities that are ...
(Date:5/21/2013)... SAN FRANCISCO , May 21, 2013 /PRNewswire/ ... meeting of the American Psychiatric Association show that ... statistically and clinically meaningful response and remission in ... acute phase of therapy, which were maintained through ... acute treatment, 62 percent of patients achieved symptomatic ...
Breaking Medicine Technology:OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 4OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 5NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 2NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 2New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 3New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation in Difficult-to-Treat Patients with Depression using NeuroStar TMS Therapy System 4
... TOKYO and CHIPPENHAM, England, October 7 ,Sosei ... and Vectura,Group plc ("Vectura"; LSE: VEC), announce ... efficacy, safety and tolerability of NVA237 presented ... Society (ERS) in Berlin,Germany. The new data ...
... of Gastroenterology Annual ... ... two Phase 3,studies presented at the American College of Gastroenterology Annual,Scientific ... rates than lansoprazole among patients with more,severe grades of erosive esophagitis ...
Cached Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 2Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: